Correction: Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer

Correction: Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer

Saved in:

Bibliographic Details
Main Authors:	Shuo-Fu Chen, Liang-Yun Wang, Yi-Sian Lin, Cho-Yi Chen
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Journal of Ovarian Research
Online Access:	https://doi.org/10.1186/s13048-025-01605-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01)

Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer.
by: Ori Tal, et al.
Published: (2025-01-01)

Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer
by: Ori Tal, et al.
Published: (2025-01-01)

TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-01-01)

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
by: Fabio Morandi, et al.
Published: (2018-01-01)

New Immunotherapeutic Approaches for Glioblastoma
by: Gustavo Ignacio Vázquez Cervantes, et al.
Published: (2021-01-01)

Immunotherapeutic Targeting in Autoimmune Diseases
by: Nona Janikashvili, et al.
Published: (2016-01-01)

Immunotherapeutic Strategies for Alzheimer's Disease Treatment
by: Beka Solomon
Published: (2009-01-01)

Vaccines and Immunotherapeutics for the Treatment of Malignant Disease
by: Joel F. Aldrich, et al.
Published: (2010-01-01)

A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma
by: Zhongjun Tang, et al.
Published: (2021-01-01)

Current Advances and Future Prospects in Cancer Immunotherapeutics
by: Zeynep DEDE, et al.
Published: (2023-03-01)

The Immunotherapeutic Effect of SIRPα-Silenced DCs against Cervical Cancer
by: Xiaojie Li, et al.
Published: (2020-01-01)

Cellular heterogeneity and cytokine signatures in acute myeloid leukemia: A novel prognostic model
by: Jinxia Cao, et al.
Published: (2025-02-01)

Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients
by: Zihan Zhu, et al.
Published: (2023-01-01)

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
by: Jiaxing Zhang, et al.
Published: (2025-02-01)

Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
by: Zhaoda Deng, et al.
Published: (2025-01-01)

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature
by: Yong Huang, et al.
Published: (2025-01-01)

Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma
by: Juan Peng, et al.
Published: (2024-01-01)

Development and Validation of an Immunotherapy-Related Prognostic Signature Based on Lymph Node Ratio for Gastric Cancer
by: Jianxin Li, et al.
Published: (2023-01-01)

A prognostic model of 8-T/B cell receptor-related signatures for hepatocellular carcinoma
by: Xuan Zuo, et al.
Published: (2025-01-01)

Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma
by: Jin Xu, et al.
Published: (2022-01-01)

Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
by: Mina Cho, et al.
Published: (2024-12-01)

Author Correction: Examining the relationships between patients’ multimorbidity trajectories and prognostic outcomes after the initial hip fracture
by: Jessica Qiuhua Sheng, et al.
Published: (2025-01-01)

Immunotherapeutic Potential of Lactobacillus Species as Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Renukadevi J, et al.
Published: (2025-01-01)

Identification of Hypoxia Signature to Assess the Tumor Immune Microenvironment and Predict Prognosis in Patients with Ovarian Cancer
by: Chunyan Wei, et al.
Published: (2021-01-01)

Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
by: Joanna Lopacinska-Jørgensen, et al.
Published: (2021-01-01)

A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma
by: Xing Jin, et al.
Published: (2022-01-01)

Ovarian Cancer Prognostic Prediction Model Using RNA Sequencing Data
by: Seokho Jeong, et al.
Published: (2018-12-01)

CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer
by: Pan Hu, et al.
Published: (2023-01-01)

Post quantum proxy signature scheme based on the multivariate public key cryptographic signature
by: Jiahui Chen, et al.
Published: (2020-04-01)

Unexpected encounters: The surprising link between ovarian cancer and axillary lymphadenopathy
by: Marina Balbino, et al.
Published: (2025-04-01)

Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer.
by: Yinghao He, et al.
Published: (2025-01-01)

Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer
by: Wei Tan, et al.
Published: (2025-01-01)

T Cell Costimulatory Molecules in Anti-Viral Immunity: Potential Role in Immunotherapeutic Vaccines
by: Tania H Watts, et al.
Published: (2003-01-01)

Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
by: Karima Oualla, et al.
Published: (2020-01-01)

Integrative prognostic modeling of ovarian cancer: incorporating genetic, clinical, and immunological markers
by: Aidi Lin, et al.
Published: (2025-02-01)

Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer
by: Katrin Kreienbring, et al.
Published: (2016-01-01)

DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer
by: Qianqian Zhao, et al.
Published: (2021-01-01)

The Effects of Different Representations on Static Structure Analysis of Computer Malware Signatures
by: Ajit Narayanan, et al.
Published: (2013-01-01)